4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-23-014615
Chief Legal Officer sold 7,500 shares at an average $24.82 ($186,136)
- Chief Legal Officer acquired 7,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Meisner Lara Chief Legal Officer | 2023-06-02 | Option exercise 10b5-1 | +1,875 | $14.00 | $26,250 | 31,846 | D |
| Meisner Lara Chief Legal Officer | 2023-06-02 | Sale 10b5-1 | −1,875 | $24.21 | $45,394 | 29,971 | D |
| Meisner Lara Chief Legal Officer | 2023-06-05 | Option exercise 10b5-1 | +499 | $18.51 | $9,236 | 30,470 | D |
| Meisner Lara Chief Legal Officer | 2023-06-05 | Sale 10b5-1 | −499 | $25.03 | $12,490 | 29,971 | D |
| Meisner Lara Chief Legal Officer | 2023-06-06 | Option exercise 10b5-1 | +5,126 | $18.51 | $94,882 | 35,097 | D |
| Meisner Lara Chief Legal Officer | 2023-06-06 | Sale 10b5-1 | −5,126 | $25.02 | $128,253 | 29,971 | D |
| Derivatives | |||||||
| Meisner Lara Chief Legal Officer | 2023-06-02 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,875 | 18,128 | D | ||
| Meisner Lara Chief Legal Officer | 2023-06-05 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −499 | 89,501 | D | ||
| Meisner Lara Chief Legal Officer | 2023-06-06 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,126 | 84,375 | D | ||
| Open-market sales · 7,500 sh · avg $24.82 · $186,136 | |||||||
Loading xslF345X04/doc4.xml…